drugset / Trial / NCT07840729
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
Use these resources to provide understandable information about this study to patients, families, and health care providers:
Timeline
- Start
- 2026-10-20
- Primary completion
- 2027-02-28
- Completion
- 2027-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JMT206 | Unknown | — | Subcutaneous |
| Subject | Semaglutide | Peptide | — | Subcutaneous |
Indications
No indication recorded.